# A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis

> **NCT03521232** · PHASE1,PHASE2 · TERMINATED · sponsor: **Entero Therapeutics** · enrollment: 27 (actual)

## Conditions studied

- Ulcerative Colitis
- Ulcerative Proctitis
- Ulcerative Proctosigmoiditis

## Interventions

- **DRUG:** Niclosamide

## Key facts

- **NCT ID:** NCT03521232
- **Lead sponsor:** Entero Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-15
- **Primary completion:** 2022-09-19
- **Final completion:** 2022-10-04
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Covid-19
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03521232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03521232, "A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03521232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*